06.06.2013
- Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...
07.05.2013
- A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new...
26.04.2013
- AbbVie reported slightly better than expected quarterly results on Friday, fueled by surging sales of its Humira treatment for rheumatoid arthritis. Sales of Humira, which accounts...
17.04.2013
- Abbott Laboratories on Wednesday reported higher quarterly earnings after splitting off its branded drug business, and the company said demand was strong for its infant formulas...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
27.02.2013
- GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...
31.01.2013
- AbbVie, the pharmaceuticals business spun off earlier this month by Abbott Laboratories, forecast 2013 earnings in line with Wall Street forecasts but slowing sales growth for...
24.01.2013
- AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...
